Agomelatine synthesis procedure and intermediates

专利摘要:

公开号:ES2583682T9
申请号:ES12703858.6T
申请日:2012-01-04
公开日:2016-10-31
发明作者:Samir Zard；Béatrice SIRE；Mehdi BOUMEDIENE
申请人:Laboratoires Servier SAS；
IPC主号:

专利说明:

Description
Agomelatine synthesis and intermediates procedure
The present invention relates to a new method of industrial synthesis of agomelatine or W- [2- (7-methoxy-1-naphthyl) ethyl] acetamide, of formula (I):
image 1
Agomelatine, or W- [2- (7-methoxy-1-naphthyl) ethyl] acetamide, has interesting pharmacological properties.
In fact, it presents the double peculiarity of being, on the one hand, agonist with respect to the receptors of the melatoninergic system and, on the other hand, antagonist of the 5-HT2C receptor. These properties confer activity on the central nervous system and more particularly in the treatment of major depression, seasonal depressions, sleep disorders, cardiovascular pathologies, digestive system pathologies, insomnia and fatigue due to 15 time lags, appetite problems and obesity. .
Agomelatine, its preparation and its therapeutic use are described in European patents EP 0 447 285 and EP 1 564 202.
Taking into account the pharmaceutical interest of this compound, it was important to be able to access it with an efficient industrial synthesis process, easily transferable to the industrial scale, to produce agomelatine with good performance and excellent purity.
EP 0 447 285 describes the access to agomelatine in eight stages from 7-methoxy-1-tetralone. In EP 1 564 202, the applicant has perfected a new way of much more efficient and industrializable synthesis, 25 in only four stages, from 7-methoxy-1-tetralone, which allows to obtain agomelatine in a very reproducible way in a crystal shape well defined. However, new ways of synthesis are still being sought, particularly from less expensive raw materials than 7-methoxy-1-tetralone.
The applicant has continued her research and has developed a new agomelatine synthesis procedure based on allyl cyanide and a xanthate derivative: these new raw materials have the advantage of being simple and easily accessible in large quantities and at a lower cost. This vfa of synthesis 5 is based on carrying out uncommon and, however, very effective radical reactions. The transposition of these reactions on an industrial scale into continuous flow reactors is promising to the extent that it is easier to control the propagation of the chain reaction. On the other hand, this new procedure makes it possible to obtain agomelatine in a reproducible way and without need of laborious purification, with a purity compatible with its use as a pharmaceutical active ingredient. Indeed, agomelatine can be synthesized in this way in 6 stages, during which only two of its intermediate products are isolated.
fifteen
More specifically, the present invention relates to a method of industrial synthesis of the compound of formula (I):
image2
characterized in that an allyl cyanide of formula (II):
(10
It is reacted with a compound of formula (IN) in the presence of a radical initiator:
image3
image4
where Xa represents a -S-C (S) -OR group, where R is a linear or branched (C1-C6) alkyl group,
to obtain the compound of formula (IV):
image5
where Xa has the meaning defined above,
The latter compound can optionally be isolated before subjecting it to a cyclization reaction in the presence of a radical initiator to form the compound of formula (V):
image6
compound of formula (V) that can optionally also be isolated,
10
which is subjected to a reduction / dehydration reaction to obtain the compound of formula (VI):
image7
which is then subjected to a flavoring reaction, to obtain the compound of formula (VII):
image8
which undergoes a reduction with hydrogen in the presence of Raney's nickel in a polar protic medium and a reaction with acetic anhydride, to obtain the compound of formula (I), which is isolated in the form of a solid.
In a preferred embodiment of the invention, the compound of formula 5 (VII) is then subjected to a reduction with hydrogen in the presence of Raney nickel in an ammoniacal ethanol medium, and then salified with hydrochloric acid to obtain the compound of formula (VIII):
HCI
image9
which is successively subjected to the action of sodium acetate and then acetic anhydride to obtain the compound of formula (I), which is sealed in the form of a solid.
Alternatively, the compound of formula (VII) can be subjected to a reduction with hydrogen in the presence of Raney nickel in a medium containing acetic anhydride in a polar protic medium, to obtain compound 15 of formula (I), which is aflame in the form of a solid.
In the preferred compound of formula (III), Xa represents a group -S-C (S) - OC2H5.
In the procedures according to the invention, the initiation of the radical reactions is carried out thermally. Preferably, the reaction medium is brought to a temperature between 50 ° C and 140 ° C. Especially preferably, the cyclization is carried out at a temperature between 130 and 135 ° C.
Peroxides are radical initiators particularly suitable for carrying out the step of adding the compound of formula (II) to the compound of formula (III), or for the cyclization of the compound of formula (IV) in the compound of formula (V). Examples include diisobutyryl peroxide, cumyl peroxineodecanoate, ferc-amyl peroxineodecanoate, di (2-ethylhexyl) peroxydicarbonate, ferc-butyl peroxyineodecanoate, dibutyl peroxy dicarbonate, dihydryloxyte peroxydicarbonate, peroxydicarbonate peroxydicarbonate ferc-butyl, ferc-amyl peroxypivalate, didecane-peroxide, ferc-amyl peroxy-2-ethylhexanoate, peroxyisobutyrate
tert-butyl, 1,4-di (tert-butylperoxycarbo) cyclohexane, tert-butyl peroxyacetate, tert-butyl peroxybenzoate, di-tert-amyl peroxide, tert-butyl peroxide, bis-tert-butyl peroxide , dicumyl peroxide, dilauryl peroxide (DLP) or di (4-tert-butylcyclohexyl) peroxydicarbonate.
5 Preferably, the reaction is initiated in the presence of dilaurophil peroxide.
The amount of dilaurophil peroxide used in the cycling preferably ranges from 1 to 2.5 equivalents. In a preferred embodiment of the invention, dilaurophil peroxide is added fractionally in the medium.
10 The addition and / or cyclization reactions take place in a solvent used classically in radical chemistry, such as 1,2-dichloroethane, dichloromethane, benzene, toluene, trifluoromethylbenzene, chlorobenzene, hexane, cyclohexane, heptane, octane, acetate ethyl, tert-butyl alcohol and mixtures thereof. Preferably, in the step of adding the compound of formula (II) to the compound of formula (III), ethyl acetate is used, while the cyclization of the compound of formula (IV) in the compound of formula (V) is advantageously performed in chlorobenzene, ethyl acetate or ethyl butyrate. In the latter case, chlorobenzene is particularly preferred.
The transformation of the compound of formula (V) into the compound of formula (VI) 20 is advantageously carried out in the presence of a Lewis acid, such as aluminum isopropoxide or samarium isopropoxide. In addition, this transformation preferably takes place in an alcohol (primary or secondary) and especially preferably in isopropanol.
Preferably once all the tetralone (V) is consumed at the end of the transformation of the compound of formula (V) into the compound of the formula (VI), a catalytic amount of p-toluenesulfonic acid is added to the mixture.
The aromatization of the compound (VI) is carried out in the presence of a quinone, preferably in the presence of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) or tetrachlorobenzoquinone (TCQ). Especially preferably, the aromatization is carried out in the presence of TCQ at reflux of toluene.
Those skilled in the art can access the compound of formula (II) by classical chemical reactions and / or described in the literature.
This procedure is particularly interesting for the following reasons:
- allows to obtain the compound of formula (I) on an industrial scale with good yields from a simple and inexpensive raw material;
- Only the intermediates of formulas (VI) and (VII) require a stage of purification and isolation.
The compounds of formulas (V) and (VI) obtained according to the process of the invention are new and useful as agomelatine synthesis intermediates.
The following examples illustrate the invention, but do not limit it in any way.
Synthesis intermediates are sharpened and systematically characterized to correctly validate the reaction path. However, the procedures can be optimized considerably by limiting the number of isolated intermediates. Thus, example 2 detailed below corresponds to the same reaction path as that taken in example 1, with the difference that only (7- methoxy-1,2-dihydro-1-naphthalenyl) acetonitrile and (7-methoxy-1-naphthyl) acetonitrile.
Example 1: W- [2- (7-methoxM-naphthyl) ethyl] acetamide
Stage A: S- [1- (cyanomethyl) -4- (4-methoxyphenyl) -4-oxobutyl] -O-ethyl dithiocarbonate
A solution of allyl cyanide (4.8 ml, 60.0 mmol) and S- [2- (4- methoxyphenyl) -2-oxoethyl] -O-ethyl1 (8.1 g, 30.0 mmol) dithiocarbonate in ethyl acetate (30 ml) it is refluxed for 15 minutes under a nitrogen atmosphere. Initially an amount of dilauroflo peroxide (10 mol%) is added to the solution under reflux. After 1h30 another amount of dilauroflo peroxide (5 mol%) is also introduced. Once the reagents are completely consumed, the mixture is cooled to room temperature and concentrated under reduced pressure. Then, the crude mixture is purified by flash column chromatography (petroleum ether - 25 ethyl acetate: 95-5 to 80-20) to obtain the compound indicated in the title as an oil with a yield of 98 %.
1 S- [2- (4-Methoxyphenyl) -2-oxoethyl] -O-ethyl dithiocarbonate is obtained according to the procedure described in Batanero, B et al., J. Org. Chem. 2001, 66, 320.
1 H NMR (5, ppm) 7.93 (m, 2H, CH-4), 6.93 (m, 2H, CH-3), 4.67-4.57 (m,
(CDCl3, 400 MHz) 2H, CH2-13), 3.99 (m, 1H, CH-9), 3.87 (s, 3H, CH3-1),
3.15 (t, 2H, J = 7.3 Hz, CH2-7), 2.95 (dd, 2H, J = 17.0, 6.0
Hz, CH2-IO), 2.41-2.31 (m, 1H, CH2-8), 2.19-2.08 (m, 1H, CH2-8), 1.41 (t, 3H, J = 7.1 Hz, CH3-14).
Stage B: (7-methoxy-4-oxo- 1,2,3,4-tetrahydro-1-naphthalenyl) acetonitrile
The compound of step A, then used without purification, is redissolved in chlorobenzene (900 ml) and the solution is refluxed for 15 minutes under a nitrogen atmosphere. Then, 5 dilaurophil peroxide is added progressively to the solution under reflux (10 mol% every 10 minutes). At the end of the reaction, the mixture is cooled to room temperature and concentrated under reduced pressure. Acetonitrile is then added to cause the precipitation of a large part of the dilaurophil peroxide derivatives. The mixture is then filtered, concentrated under reduced pressure and purified by flash column chromatography (petroleum ether - ethyl acetate: 60-40) to obtain the compound indicated in the form as a solid with a solid. 40% yield.
HRMS (EI, m / z) Calculated for C13H13NO2: 215.0946; Found: 215.0946.
Stage C: (7-methoxy-1,2-dihydro-1-naphthalenyl) acetonitrile
To a solution of the compound obtained in step B (680 mg, 3.15 mmol) in 15 isopropanol (15 ml) at room temperature is added aluminum isopropoxide (2.05 g, 10.0 mmol). The reaction mixture is refluxed. Once the reagents are completely consumed, crystals of p-toluenesulfonic acid monohydrate are added and a Dean-Stark apparatus is installed on the top of the flask. The mixture is refluxed again for 1 hour, during which 20 isopropanol is gradually replaced by toluene with the aid of the Dean-Stark apparatus. Next, a 1N HCl solution is added and the resulting phases are separated. The aqueous phase is extracted with ethyl acetate, while the organic phases are washed with a saturated NaHCO3 solution, with a saturated NaCl solution, then dried over MgSO4, filtered and concentrated under reduced pressure. The residue is purified by column chromatography (petroleum ether - ethyl acetate: 80-20) to obtain the product indicated in the form in the form of an oil with a yield of 85%.
HRMS (EI, m / z) Calculated for C13H13NO: 199.0997; Found: 199.1001.
Stage D: (7-methoxy-1-naphthyl) acetonitrile
30 Method A:
To a solution of the compound obtained in step C (1.0 g, 5.0 mmol) in dichloromethane (50 ml) at room temperature is added DDQ (1.4 g, 6.0 mmol). The reaction mixture is stirred for 2 days, then washed with a saturated NaHCO3 solution. The aqueous phase is extracted with ethyl acetate, while the organic phase is washed with a saturated NaCl solution, dried over MgSO4, filtered and concentrated under reduced pressure. The residue is purified by column chromatography (petroleum ether - ethyl acetate: 80-20) to obtain the product indicated in the form as a solid with a yield of 55%.
10 Method B:
To a solution of TCQ (615 mg, 2.5 mmol) in toluene (1.5 ml) heated to 80 ° C the compound obtained in step C (472 mg, 2.3 mmol) dissolved in toluene is added ( 3.5 ml) The mixture is then refluxed for 2.5 hours, then diluted in water and extracted with petroleum ether. The organic phase is washed with a NaOH solution (30% by weight) and with water, then dried over MgSO4, filtered and concentrated under reduced pressure. The residue is purified by column chromatography (petroleum ether - ethyl acetate: 80-20) to obtain the product indicated in the form as a solid with a yield of 61%.
HRMS (EI, m / z) Calculated for C13H11NO: 197.0841; Found: 197.0838.
Stage E: N- [2- (7-methoxy-1-naphthyl) ethyl] acetamide
The reaction is carried out in a larger load in order to optimize the performance obtained:
In an 8-liter reactor 136 g of Raney nickel, 2.06 l of ethanol 25 and 0.23 l of water are introduced. Then the compound obtained in step D (0.8 kg) in solution in acetic anhydride (2.4 L) is slowly added, under stirring at 70 ° C and under 30 bars of hydrogen. At the end of the addition, the reaction medium is stirred for 1 hour under hydrogen at 30 bar, then the reactor is decompressed and the juices are filtered. After concentrating the medium, the residue is crystallized in a 35/65 ethanol / water mixture to obtain the product indicated in the label with a yield of 89% and a chemical purity greater than 99%.
Melting Point: 108 ° C
Example 2: N- [2- (7-methoxM-naphthyl) etM] acetamide
Stage A: (7-methoxy-1,2-dihydro-1-naphthalenyl) acetonitrile
A solution of allyl cyanide (6.75 ml, 84.0 mmol) and S- [2- (4- methoxyphenyl) -2-oxoethyl] -0-ethyl1 (11.3 g, 42.0 mmol) dithiocarbonate in ethyl acetate (45 ml) it is refluxed for 15 minutes under nitrogen atmosphere. Initially an amount of dilauroflo peroxide (10 mol%) is added to the reflux solution. After 1h30, another amount of dilaurophil peroxide (5 mol%) is added. Once the reagents are completely consumed, the mixture is cooled to room temperature and concentrated under reduced pressure. The crude mixture is redissolved in chlorobenzene (640 ml) and the solution is refluxed for 10 minutes under a nitrogen atmosphere. Then progressively add dilaurophil peroxide to the solution at reflux (10 mol% every 10 minutes). At the end of the reaction, the mixture is cooled to room temperature and concentrated under reduced pressure. Acetonitrile is then added to cause the precipitation of a large part of the dilaurophil peroxide derivatives. Then, the mixture is filtered and concentrated under reduced pressure. The crude oil fraction thus obtained is redissolved in isopropanol (100 ml) at room temperature in the presence of aluminum isopropoxide (13.6 g, 66.6 mmol). The reaction mixture is refluxed. Once the reagents have been completely consumed, crystals of p-toluenesulfonic acid monohydrate are added and a Dean-Stark apparatus is installed at the top of the flask. The mixture is refluxed again for 2 hours, during which the isopropanol is gradually replaced by toluene with the aid of the Dean-Stark apparatus. Next, a 1N HCl solution is added and the resulting phases are separated. The aqueous phase is extracted with ethyl acetate, while the organic phases are washed with a saturated NaHCO3 solution, with a saturated NaCl solution, then dried over MgSO4, filtered and concentrated under reduced pressure. The residue is purified by column chromatography (petroleum ether - ethyl acetate: 80-20) to obtain the product indicated in the title in the form of an oil with a yield of 24%.
HRMS (EI, m / z) Calculated for C13H13NO: 199.0997; Found: 199.1001.
Stage B: (7-methoxy-1-naphthyl) acetonitrile
Step D of Example 1 is carried out analogously.
Stage C: N- [2- (7-methoxy-1-naphthyl) ethyl] acetamide
Step E of Example 1 is carried out analogously.
-10 -

权利要求:
Claims (15)
[1]
one.
5
10
fifteen
Claims
Industrial synthesis procedure of the compound of formula (I):
image 1
characterized in that an allyl cyanide of formula (II):
image2
It is reacted with a compound of formula (III) in the presence of a radical initiator:
image3
where Xa represents a -S-C (S) -OR group, where R is a linear or branched (C1-C6) alkyl group,
to obtain the compound of formula (IV):
image4
where Xa has the meaning defined above,
The latter compound can optionally be isolated before subjecting it to a cyclization reaction in the presence of a radical initiator to obtain the compound of formula (V):
5
10
[2]
2.
fifteen
image5
compound of formula (V) that can optionally also be isolated,
which is subjected to a reduction / dehydration reaction to obtain the compound of formula (VI):
image6
which is then subjected to a flavoring reaction, to obtain the compound of formula (VII):
image7
which undergoes a reduction with hydrogen in the presence of Raney's nickel in a polar protic medium and a reaction with acetic anhydride to obtain the compound of formula (I), which is isolated in the form of a solid.
Method of synthesis of the compound of the formula (I) according to claim 1, characterized in that the compound of formula (VII) is then subjected to a reduction with hydrogen in the presence of Raney nickel in an ammoniacal ethanol medium and then salified with hydrochloric acid to obtain the compound of formula (VIII):
image8
which is successively subjected to the action of sodium acetate and then acetic anhydride to obtain the compound of formula (I), which is sealed in the form of a solid.
5 3. Synthesis procedure of the compound of the formula (I) according to the
claim 1, characterized in that the compound of formula (VII) is subjected to a reduction with hydrogen in the presence of Raney's nickel in a medium containing acetic anhydride in a polar protic medium, to obtain the compound of formula (I), which is afsla in the form of a solid.
10 4. Synthesis procedure of the compound of formula (I) according to the
claim 1, characterized in that the group Xa = -S-C (S) -OC2H5.
[5]
5. Method of synthesis of the compound of formula (I) according to claim 1, characterized in that the radical reactions are initiated thermally at a temperature between 50 ° C and 140 ° C.
15 6. Synthesis procedure of the compound of formula (I) according to the
claim 1, characterized in that the cyclization of the compound of formula (IV) is carried out at a temperature between 130 and 135 ° C.
[7]
7. Synthesis procedure of the compound of formula (I) according to the
claim 1, characterized in that the step of adding the compound
20 of formula (II) to the compound of formula (III) and the cyclization step of the
Compound of formula (IV) are initiated in the presence of dilaurophil peroxide.
[8]
8. Synthesis procedure of the compound of formula (I) according to the
claim 1, characterized in that the step of adding the compound
From formula (II) to the compound of formula (III) takes place in chlorobenzene.
[9]
9. Synthesis procedure of the compound of formula (I) according to the
claim 1, characterized in that the cyclisation step of the adduct of formula (IV) in the compound of formula (V) takes place in ethyl acetate.
5
10
fifteen
twenty
25
[10]
10. Synthesis method according to claim 1, characterized in that the transformation of the compound of formula (V) into the compound of formula (VI) is carried out in the presence of aluminum isopropoxide.
[11]
11. Synthesis method according to claim 1, characterized in that the transformation of the compound of formula (V) into the compound of formula (VI) is carried out in isopropanol.
[12]
12. Synthesis method according to claim 1, characterized in that a catalytic amount of p-toluenesulfonic acid is added to the mixture resulting from the transformation of the compound of formula (V) into the compound of formula (VI).
[13]
13. Synthesis method according to claim 1, characterized in that the aromatization of the compound of formula (VI) is carried out in the presence of a quinone.
[14]
14. Synthesis method according to claim 1, characterized in that the aromatization of the compound of formula (VI) is carried out in the presence of TCQ tetrachlorobenzoquinone at toluene reflux.
[15]
15. Compound of formula (V) according to claim 1, useful as a synthetic intermediate of the agomelatine of formula (I) according to claim 1.
[16]
16. Use of the compound of formula (V) according to claim 15 in the synthesis of the agomelatine of formula (I) according to claim 1.
[17]
17. Compound of the formula (VI) according to claim 1, useful as a synthetic intermediate of the agomelatine of formula (I) according to claim 1.
[18]
18. Use of the compound of the formula (VI) according to claim 17 in the synthesis of the agomelatine of formula (I) according to claim 1.

类似技术:

---

公开号 | 公开日 | 专利标题

---

KR101135336B1|2012-04-17|New process for the synthesis of agomelatine

---

ES2583682T3|2016-09-21|Agomelatine synthesis procedure and intermediates

---

JP5021004B2|2012-09-05|A novel method for synthesis of agomelatine

---

RU2680243C1|2019-02-19|Novel method for synthesis of 7-methoxy-naphthalene-1-carbaldehyde and use thereof in synthesis of agomelatine

---

US8871975B2|2014-10-28|Process for the synthesis of agomelatine

---

NZ612173B2|2015-12-01|Process and intermediates for synthesizing agomelatine

同族专利:

---

公开号 | 公开日

---

JO3200B1|2018-03-08|

---

RS54753B9|2019-09-30|

---

AP3609A|2016-02-26|

---

TWI438180B|2014-05-21|

---

FR2970000B1|2013-01-04|

---

SI2661422T1|2016-08-31|

---

TW201309623A|2013-03-01|

---

US20130289307A1|2013-10-31|

---

KR20130115345A|2013-10-21|

---

ZA201305027B|2014-03-26|

---

JP5837616B2|2015-12-24|

---

HK1189571A1|2014-06-13|

---

SG191733A1|2013-08-30|

---

EP2661422A1|2013-11-13|

---

ME02408B|2016-09-20|

---

WO2012113999A1|2012-08-30|

---

PL2661422T3|2016-10-31|

---

ECSP13012735A|2013-09-30|

---

CU20130092A7|2013-08-29|

---

RS54753B1|2016-10-31|

---

EA201300794A1|2014-02-28|

---

CR20130301A|2013-08-08|

---

ES2583682T3|2016-09-21|

---

NI201300062A|2013-12-11|

---

JP2014509309A|2014-04-17|

---

USRE46218E1|2016-11-29|

---

IL227281D0|2013-09-30|

---

WO2012113999A8|2013-08-01|

---

RU2550812C2|2015-05-20|

---

CY1117774T1|2017-05-17|

---

CL2013001882A1|2013-12-06|

---

MY162977A|2017-07-31|

---

CU24289B1|2017-12-08|

---

CN103313965A|2013-09-18|

---

HUE028471T2|2016-12-28|

---

CA2823587A1|2012-08-30|

---

EP2661422B9|2016-09-07|

---

EP2661422B1|2016-04-20|

---

KR101543432B1|2015-08-10|

---

US8853449B2|2014-10-07|

---

UA104122C2|2013-12-25|

---

SA3573B1|2014-08-25|

---

AU2012220474A1|2013-07-11|

---

AP2013007022A0|2013-07-31|

---

IL227281A|2015-06-30|

---

CO6731101A2|2013-08-15|

---

UY33845A|2012-07-31|

---

EA022077B1|2015-10-30|

---

CN103313965B|2015-08-05|

---

HRP20160713T1|2016-07-29|

---

RU2013136344A|2015-02-10|

---

FR2970000A1|2012-07-06|

---

AR084780A1|2013-06-26|

---

PE20140037A1|2014-02-01|

---

CA2823587C|2015-11-24|

---

NZ612173A|2015-08-28|

---

AU2012220474B2|2015-08-20|

---

BR112013017307A2|2016-10-04|

---

MX2013007837A|2013-09-06|

---

GEP20156365B|2015-09-10|

---

DK2661422T3|2016-10-24|

---

TN2013000274A1|2014-11-10|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

FR2658818B1|1990-02-27|1993-12-31|Adir Cie|NOVEL DERIVATIVES WITH NAPHTHALENIC STRUCTURE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.|

---

FR2866334B1|2004-02-13|2006-05-26|Servier Lab|NOVEL PROCESS FOR THE SYNTHESIS OF ACETONITRILE AND APPLICATION TO THE SYNTHESIS OF AGOMELATIN|

---

FR2866335B1|2004-02-13|2006-05-26|Servier Lab|NEW PROCESS FOR THE SYNTHESIS OF AGOMELATIN|

---

CN101486665B|2009-03-03|2013-04-17|上海医药工业研究院|Preparation of agomelatine intermediate 2- acetamide|CN103058879B|2012-12-20|2015-09-09|安徽悦康凯悦制药有限公司|The preparation method of Agomelatine|

---

CN103804232B|2014-01-26|2015-08-19|江西同和药业股份有限公司|A kind of 1-cyano group-1- methanol esters compounds and its preparation method and application|

---

CN107353229B|2017-08-08|2019-04-30|许昌恒生制药有限公司|A kind of preparation method of agomelatine intermediate body|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

FR1100024|2011-01-05|

---

FR1100024A|FR2970000B1|2011-01-05|2011-01-05|NEW PROCESS FOR THE SYNTHESIS OF AGOMELATIN|

---

PCT/FR2012/000005|WO2012113999A1|2011-01-05|2012-01-04|Process and intermediates for synthesizing agomelatine|

---